CANbridge Pharmaceuticals and GC Pharma Announce Greater China Licensing Agreement for Hunterase™ for Hunter Syndrome

Life Science

Ascentage Pharma Forms Clinical Collaboration with MD Anderson Center

Life Science

3SBio and Samsung Bioepis enter biosimilar collaboration agreement

Life Science

Acreage Holdings Acquires Nature’s Way Nursery of Miami, Inc.

Cannabis, Life Science

Invictus and CannAmerica Combine to Enter Hemp and CBD Market in the US

Cannabis, Life Science

Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders

Life Science

Schrödinger Closes $85 Million Financing to Advance Computational Platform and Expand Drug Discovery Pipeline

Life Science

Suzhou’s BrightGene Bio-Medical Completes $80 Million Pre-IPO Funding

Life Science

Cannabis Trends to Watch in 2019

Cannabis, Life Science

OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology

Life Science

Canadian M&A seen rising after hitting 12-year high in 2018

Cannabis, Life Science

Beijing InnoCare Raises $160 Million for Cancer/Autoimmune Drugs

Life Science

Athenex Out-Licenses China Rights to Keratosis/Oncology Drug for $29.5 Million

Life Science

TILT Holdings Agrees to Acquire Jupiter Research

Cannabis, Life Science

StemCyte Receives Phase II Investigational New Drug (IND) Clearance from the U.S. Food and Drug Administration (FDA)

Life Science